摘要

ObjectivesInvariant natural killer T (iNKT) cells are unique subset of glycolipid-reactive T lymphocytes with potent antitumour characteristics. This study was planned to understand Th-like cytokine profiles of iNKT-cell subsets and modulation of their functions in response to glycolipid ligand and tumour cell lysate (TL). Subjects and MethodsCytokine profile of iNKT-cell subsets was evaluated from the peripheral blood of eight oral squamous cell carcinoma (OSCC) patients by flow cytometry and enzyme-linked immunosorbent assay (ELISA), while antitumour activity of iNKT cells was measured by methyl tetrazolium salt assay. ResultsCD4(+) (CD4(+)CD8(-)) iNKT subset from OSCC patients showed significant (P<0.01) expansion and higher IL-4 production following activation with -GalCer-pulsed DCs, while CD4(-)CD8(-) double negative (DN) and CD8(+) (CD4(-)CD8(+)) iNKT subsets produced IFN- predominantly. iNKT cells showed significantly (P=0.02) increased secretion of IFN- and enhanced cytotoxicity to KB and SCC-4 tumour cells in response to -GalCer and TL-pulsed DCs. ConclusionIt appears that mutual balance/ratio of iNKT subsets may be important for their effector functions. Selectively expanded DN and CD8(+) iNKT cells with -GalCer and TL may be a better candidate vaccine for iNKT-cell-based adoptive cancer immunotherapy.